Home About us Contact
|
Home About us Contact | ||
|
|
||
Reported Differences (reported + difference)
Selected AbstractsPatterns of Nest Predation on Artificial and Natural Nests in ForestsCONSERVATION BIOLOGY, Issue 2 2004DAWN M. BURKE ave de bosque; depredación de nidos; éxito de nidos; experimento de nidos artificiales; nidos naturales Abstract:,Artificial nest experiments have been used in an attempt to understand patterns of predation affecting natural nests. A growing body of literature suggests that neither relative rates nor patterns of predation are the same for artificial and natural nests. We studied nest predation and daily mortality rates and patterns at real and artificial ground and shrub nests to test the validity of artificial nest experiments. We monitored 1667 artificial and 344 natural nests, over seven trials, in three regions, across 58 sites in Ontario. We controlled for many of the factors thought to be responsible for previously reported differences between predation rates on natural and artificial nests. Although artificial nests in our study resembled natural nests, contained eggs of appropriate size, shape, and color of target bird species, and were placed in similar microhabitats as natural nests, the rates of predation on these nests did not parallel rates on natural nests for any region in terms of absolute rate or pattern. Predation rates on artificial nests did not vary between years, as they tended to for natural nests, and the magnitude of predation pressure on artificial ground nests compared with shrub nests did not show the same pattern as that on natural nests. In general, rates of predation on artificial nests were significantly higher than on natural nests. Our results suggest that conclusions derived from artificial nest studies may be unfounded. Given that many influential ideas in predation theory are based on results of artificial nest experiments, it may be time to redo these experiments with natural nests. Resumen:,Se han utilizado experimentos con nidos artificiales con la intención de entender los patrones de depredación que afectan a los nidos naturales. La bibliografía sugiere que ni las tasas relativas ni los patrones de depredación son iguales para nidos artificiales y naturales. Estudiamos las tasas y patrones de depredación de nidos y de mortalidad diaria en nidos reales y artificiales sobre el suelo y en matorrales para probar la validez de los experimentos con nidos artificiales. Monitoreamos 1667 nidos artificiales y 344 nidos naturales, en siete pruebas, en tres regiones, en 58 sitios en Notario. Controlamos muchos de los factores que se piensa son responsables de diferencias entre tasas de depredación en nidos naturales y artificiales reportadas previamente. Aunque los nidos artificiales en nuestro estudio se asemejaron a nidos naturales, contenían huevos de tamaño, forma y color adecuados para la especie de ave y fueron colocados en microhábitats similares a los de nidos naturales, las tasas de depredación en estos nidos no fueron similares a las tasas en nidos naturales en ninguna región en términos de tasa o patrón absoluto. Las tasas de depredación en nidos artificiales no variaron de un año a otro, como fue la tendencia en nidos naturales, y la magnitud de la presión de depredación en nidos sobre el suelo comparada con nidos en arbustos no mostró el mismo patrón que la depredación en nidos naturales. Nuestros resultados sugieren que las conclusiones derivadas de estudios con nidos artificiales pueden ser infundadas. Debido a que muchas ideas influyentes en la teoría de la depredación se basan en los resultados de experimentos con nidos artificiales, puede haber llegado el momento de volver a realizar estos experimentos utilizando nidos naturales. [source] The Efficacy of Acamprosate in the Maintenance of Abstinence in Alcohol-Dependent Individuals: Results of a Meta-AnalysisALCOHOLISM, Issue 1 2004Karl Mann Abstract: Background: A number of clinical trials have been undertaken to determine the efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals. However, the reported differences in patient populations, treatment duration, and study endpoints make comparisons difficult. An assessment of the efficacy of treatment with acamprosate was, therefore, undertaken using meta-analytical techniques. Methods: All randomized, placebo-controlled trials (RCTs) that fulfilled predetermined criteria were identified using (1) a language unrestricted search of 10 electronic databases; (2) a manual search of relevant journals, symposia, and conference proceedings; (3) cross-referencing of all identified publications; (4) personal communications with investigators; and (5) scrutiny of Merck-Santé's internal reports of all European trials. Study quality was assessed, independently, by three blinded workers. Key outcome data were identified; some outcome variables were recalculated to ensure consistency across trials. The primary outcome measure was continuous abstinence at 6 months; abstinence rates were determined by estimating Relative Benefit (RB). Results: A total of 19 published 1 unpublished RCTs were identified that fulfilled the selection criteria; 3 were excluded because the documentation available was insufficient to allow adequate assessment. The remaining 17 studies, which included 4087 individuals, 53% of whom received active drug, were of good quality and were otherwise reasonably comparable. There was no evidence of publication bias. Continuous abstinence rates at 6 months were significantly higher in the acamprosate-treated patients (acamprosate, 36.1%; placebo, 23.4%; RB, 1.47; [95% confidence intervals (CI): 1.29,1.69]; p < 0.001). This effect was observed independently of the method used for assigning missing data. The effect sizes in abstinent rates at 3, 6, and 12 months were 1.33, 1.50, and 1.95, respectively. At 12 months, the overall pooled difference in success rates between acamprosate and placebo was 13.3% (95% CI, 7.8,18.7%; number needed to treat, 7.5). Acamprosate also had a modest but significant beneficial effect on retention (6.01%; [95% CI, 2.90,8.82]; p= 0.0106). Conclusion:: Acamprosate has a significant beneficial effect in enhancing abstinence in recently detoxified, alcohol-dependent individuals. [source] Skin reactivity to histamine and to allergens in unselected 9-year-old children living in Poland and ItalyPEDIATRIC ALLERGY AND IMMUNOLOGY, Issue 3 2003Roberto Ronchetti Several studies have shown a higher prevalence of positive skin-prick tests to airborne allergens in Western than in Eastern European countries. We have recently reported that skin histamine reactivity significantly increased in Italy over the past 15 years. Population differences in skin histamine reactivity could, at least in part, explain the reported differences in positive allergen skin tests. To test this hypothesis we compared histamine skin reactivity and the prevalence of allergen positive skin-prick tests in a sample of Italian and Polish schoolchildren. A total of 336 unselected 9-year-old-schoolchildren (198 in Italy and 138 in Poland) underwent skin-prick tests with three different histamine concentrations (10, 1 and 0.2 mg/ml) and with a panel of common airborne allergens according to the ISAAC protocol, phase two. Mean wheals elicited by skin-prick tests with the three serial concentrations of histamine were significantly larger (p < 0.001) and shifted more toward higher values (p < 0.001) in Italian than in Polish children. The differences were greater for the intermediate histamine concentration tested (1 mg/ml) than for the highest concentration (10 mg/ml). Skin-prick tests for airborne allergens were more frequently positive in Italian children: wheals ,,3 mm induced by any allergen [odds ratio (OR) 1.69; confidence interval (CI) 0.98,2.92] by Dermatophagoides pteronyssinus (OR 1.92; CI 0.97,3.80) and by D. farinae (OR 3.15; CI 1.16,8.63). Labeling as positive allergen wheal reactions half the size of the 10 mg/ml histamine wheal or larger reduced but did not abolish the Italian,Polish differences. The significantly higher skin histamine reactivity observed in Italian children could help to explain why allergen skin-test reactions differ in the East and West European populations. Moreover, differences in nonallergen-specific factors among populations should be considered in the interpretation of skin test results (e.g. cut-off points). To obtain meaningful results, epidemiological studies of allergies should include serial histamine dilutions. [source] Epidemiology of abdominal aortic aneurysm in an Asian populationANZ JOURNAL OF SURGERY, Issue 6 2003Ming Kon Yii Background: Abdominal aortic aneurysms (AAA) are common in the Caucasian population. Apart from reported differences in the occurrence of AAA in the black and white populations, there are few studies on the incidence of AAA in the Asian population. Methods: A prospective database of all patients with AAA seen between 1996 and 1999, in the South-East Asian state of Sarawak in Borneo Island, was analysed. The demographic data included patient's age, sex, ethnic group, date of diagnosis, comorbidities, presentations and treatment outcomes. These were compared with the state population's demographic statistics. Results: Diagnoses of AAA were made in 123 patients during the study period. The male to female ratio was 3.5 : 1. The age range was 39,88 years with a median age of 70 years. Four patients were younger than 55 years. The incidence rate for the at-risk male population older than 50 years was 25.6/100 000. The incidence rate reached 78.3/100 000 for males older than 70 years. The incidence rate for females older than 50 years was 7.6/100 000 and for those older than 70 years it was 18.7/100 000. All races were affected. Smoking, hypertension or respiratory disorders were present in more than 40% of the patients. Half of the patients underwent surgical repair. Conclusion: This study shows that AAA in this Asian population is not uncommon and the incidence is comparable to the Western world. [source] Antiretroviral therapy and preterm delivery,a pooled analysis of data from the United States and EuropeBJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Issue 11 2010CL Townsend Please cite this paper as: Townsend C, Schulte J, Thorne C, Dominguez K, Tookey P, Cortina-Borja M, Peckham C, Bohannon B, Newell M, for the Pediatric Spectrum of HIV Disease Consortium, the European Collaborative Study and the National Study of HIV in Pregnancy and Childhood. Antiretroviral therapy and preterm delivery,a pooled analysis of data from the United States and Europe. BJOG 2010;117:1399,1410. Objective, To investigate reported differences in the association between highly active antiretroviral therapy (HAART) in pregnancy and the risk of preterm delivery among HIV-infected women. Design, Combined analysis of data from three observational studies. Setting, USA and Europe. Population, A total of 19 585 singleton infants born to HIV-infected women, 1990,2006. Methods, Data from the Pediatric Spectrum of HIV Disease project (PSD), a US monitoring study, the European Collaborative Study (ECS), a consented cohort study, and the National Study of HIV in Pregnancy and Childhood (NSHPC), the United Kingdom and Ireland surveillance study. Main outcome measure, Preterm delivery rate (<37 weeks of gestation). Results, Compared with monotherapy, HAART was associated with increased preterm delivery risk in the ECS (adjusted odds ratio [AOR] 2.40, 95% CI 1.49,3.86) and NSHPC (AOR 1.43, 95% CI 1.10,1.86), but not in the PSD (AOR 0.92, 95% CI 0.67,1.26), after adjusting for relevant covariates. Because of heterogeneity, data were not pooled for this comparison, but heterogeneity disappeared when HAART was compared with dual therapy (P = 0.26). In a pooled analysis, HAART was associated with 1.5-fold increased odds of preterm delivery compared with dual therapy (95% CI 1.19,1.87, P = 0.001), after adjusting for covariates. Conclusions, Heterogeneity in the association between HAART and preterm delivery was not explained by study design, adjustment for confounders or a standard analytical approach, but may have been the result of substantial differences in populations and data collected. The pooled analysis comparing HAART with dual therapy showed an increased risk of preterm delivery associated with HAART. [source] A Comparison of the Effects of Olopatadine and Ketotifen on Model MembranesACTA OPHTHALMOLOGICA, Issue 2000Howard Brockman ABSTRACT. Olopatadine is a human conjunctival mast cell stabilizer with anti-histaminic activity. Ketotifen is an older molecule that possesses antihistaminic activity and is reported to have additional pharmacological properties. The interactions of these two compounds with model membranes (i.e., monolayers of 1-stearoyl-2-oleoyl-sn-glycerophosphocholine at the argon-buffer interface), and natural (i.e., erythrocyte) membranes were compared in an effort to understand the differences in their biological activities. Drug-lipid interaction with monolayers was determined by monitoring the surface pressure as a function of the drug concentration in the aqueous phase supporting the monolayer. Drug interaction with erythrocyte membranes was determined by monitoring changes in the permeability of the membranes to hemoglobin and 6-carboxyfluorescein as a function of drug concentration in the medium. Olopatadine and ketotifen are both intrinsically surface active and both interact with phospholipid monolayers. However, in both the presence and absence of lipid monolayers, the changes in surface pressure induced by olopatadine are lower than those caused by ketotifen. The effects of these two drugs on cell membranes were dramatically different. Exposure of bovine erythrocytes to increasing concentrations of ketotifen (1,10 mM) resulted in complete hemolysis of the cells, whereas olopatadine (1,10 mM) caused only minimal hemolysis (<8%). Consistent results were obtained in experiments measuring the leakage of 6-carboxyfluorescein from erythrocyte ghosts as a more sensitive marker of membrane perturbation. Olopatadine treatment (0.1,10 mM) minimally perturbed the cell membrane while ketotifen (1,10 mM) caused a concentration dependent release of the fluorescent marker. These data demonstrate fundamental differences between the two drugs in their effects on cell membranes. Moreover, the differences are consistent with the surface activities of the two compounds measured in monolayers and with reported differences in their pharmacological activities. These findings offer an explanation for the biphasic non-specific cytotoxic effect of ketotifen on histamine release from mast cells and may account for the non-lytic mast cell stabilizing activity of olopatadine. [source] Molecular homochirality and the parity-violating energy difference.CHIRALITY, Issue 2 2008A critique with new proposals Abstract Previous proposals for the origin of molecular homochirality, based on the effect of the weak neutral current (WNC) on enantiomers, and the amplification of the resultant parity-violating energy difference (PVED), are possibly flawed. The additive amplification of PVED in crystals and polymers ("Yamagata hypothesis") cannot lead to detectable levels of optical activity, the original theory apparently overestimating PVED by a factor equal to Avogadro's number. An alternative theory based on the irreversible and spontaneous evolution of a dynamically fluctuating system is apparently impractical. However, the nonlinear amplification of PVED via autocatalytic polymerization may be possible as indicated by a simplified physico-chemical approach. This may also occur during crystallization and melting, and form the basis of the second order asymmetric transformation. (Thus, reported differences in the melting points of enantiomers in several cases may well be real). Also, the preponderance of racemic compounds over conglomerates may be based on the destabilization of the conglomerate by the action of the WNC on the crystalline lattice. The WNC may also be involved in the anomalous scattering of X-rays, which possibly arises from their circular polarization: the current theory would need to be revised accordingly. Chirality, 2008. © 2007 Wiley-Liss, Inc. [source] | ||||||||||